0.1683
price up icon17.04%   0.0245
 
loading
전일 마감가:
$0.1438
열려 있는:
$0.1706
하루 거래량:
96.93M
Relative Volume:
47.17
시가총액:
$5.58M
수익:
-
순이익/손실:
$-22.71M
주가수익비율:
-0.0144
EPS:
-11.71
순현금흐름:
$-18.24M
1주 성능:
-20.69%
1개월 성능:
-36.97%
6개월 성능:
-57.19%
1년 성능:
-75.96%
1일 변동 폭
Value
$0.1566
$0.1887
1주일 범위
Value
$0.14
$0.2499
52주 변동 폭
Value
$0.14
$3.97

Genprex Inc Stock (GNPX) Company Profile

Name
명칭
Genprex Inc
Name
전화
512-537-7997
Name
주소
1601 TRINITY STREET, BLDG. B, AUSTIN, TX
Name
직원
15
Name
트위터
@genprex
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
GNPX's Discussions on Twitter

GNPX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
GNPX
Genprex Inc
0.1683 6.39M 0 -22.71M -18.24M -11.71
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Genprex Inc Stock (GNPX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2021-01-26 개시 National Securities Buy
2019-04-29 개시 Noble Capital Markets Outperform

Genprex Inc 주식(GNPX)의 최신 뉴스

pulisher
Aug 20, 2025

Trend analysis for Genprex Inc. this weekEarnings Overview Summary & AI Driven Stock Movement Reports - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Is Genprex Inc. forming a bottoming base2025 Geopolitical Influence & Advanced Swing Trade Entry Plans - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Visual trend scoring systems applied to Genprex Inc.IPO Watch & Target Return Focused Picks - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Genprex Inc. stock daily chart insights2025 Valuation Update & High Accuracy Trade Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Leading vs lagging indicators on Genprex Inc. performanceQuarterly Performance Summary & Community Trade Idea Sharing Platform - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Earnings visualization tools for Genprex Inc.Earnings Risk Summary & Reliable Trade Execution Plans - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Exit strategy if you’re trapped in Genprex Inc.Weekly Trade Summary & AI Optimized Trading Strategy Guides - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

Genprex Receives Notice of Allowance for Multiple Patents for Reqorsa® Gene Therapy with PD-L1 and PD-1 Antibodies to Treat Cancers - Eastern Progress

Aug 19, 2025
pulisher
Aug 19, 2025

What MACD signals say about Genprex Inc.July 2025 Reactions & Free Growth Oriented Trading Recommendations - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Published on: 2025-08-19 14:58:20 - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Has Genprex Inc. formed a bullish divergenceAnalyst Upgrade & Accurate Intraday Trade Tips - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Predicting Genprex Inc. trend using moving averagesWeekly Trend Report & AI Enhanced Execution Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Technical analysis overview for Genprex Inc. stockJuly 2025 Snapshot & High Accuracy Trade Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

News impact scoring models applied to Genprex Inc.Quarterly Growth Report & AI Forecast Swing Trade Picks - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Statistical indicators supporting Genprex Inc.’s strengthMarket Risk Analysis & Long-Term Safe Investment Plans - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

How to manage a losing position in Genprex Inc.Portfolio Value Report & Risk Adjusted Swing Trade Ideas - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Genprex Secures Patent Allowances for Gene Therapy - MSN

Aug 19, 2025
pulisher
Aug 18, 2025

How to build a custom watchlist for Genprex Inc.July 2025 Outlook & Fast Entry and Exit Trade Plans - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Genprex Secures US, EU Patents for its Oncology Drug Reqorsa - Mexico Business News

Aug 18, 2025
pulisher
Aug 18, 2025

Genprex receives notice of allowance for multiple patents for Reqorsa - TipRanks

Aug 18, 2025
pulisher
Aug 18, 2025

Genprex Says US, EU Issue Patent Allowances for Reqorsa Combination Therapies - MarketScreener

Aug 18, 2025
pulisher
Aug 18, 2025

Genprex receives patent allowances for cancer therapy combinations - Investing.com

Aug 18, 2025
pulisher
Aug 18, 2025

Genprex Receives Notice of Allowance for Multiple Patents for Reqorsa Gene Therapy in Combination with Immune Checkpoint Inhibitors to Treat Cancers - AInvest

Aug 18, 2025
pulisher
Aug 18, 2025

Patent Protection Until 2037: Genprex Strengthens Reqorsa Cancer Therapy IP Portfolio Globally - Stock Titan

Aug 18, 2025
pulisher
Aug 18, 2025

Comparing Genprex Inc. in custom built stock radarsWeekly Trade Report & Free High Accuracy Swing Entry Alerts - Newser

Aug 18, 2025
pulisher
Aug 17, 2025

Why Genprex Inc. stock attracts strong analyst attentionJuly 2025 Summary & Expert Verified Movement Alerts - thegnnews.com

Aug 17, 2025
pulisher
Aug 17, 2025

Is Genprex Inc. stock reversal real or fakeEarnings Trend Report & Growth Focused Stock Pick Reports - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Is Genprex Inc. stock suitable for long term investingWeekly Profit Summary & Scalable Portfolio Growth Ideas - thegnnews.com

Aug 17, 2025
pulisher
Aug 17, 2025

Is Genprex Inc. stock bottoming outPortfolio Value Summary & Stepwise Swing Trade Plans - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Will Genprex Inc. stock benefit from interest rate changesForecast Cut & Precise Buy Zone Identification - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Genprex Inc. stock trend forecastTrade Volume Summary & Risk Controlled Stock Pick Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Using fundamentals and technicals on Genprex Inc.Forecast Cut & AI Forecast Swing Trade Picks - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Genprex Stockholders Approve Key Proposals at Annual Meeting - MSN

Aug 16, 2025
pulisher
Aug 15, 2025

Price action breakdown for Genprex Inc.Market Performance Report & Weekly Stock Performance Updates - Newser

Aug 15, 2025

Genprex Inc (GNPX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
자본화:     |  볼륨(24시간):